Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Challenges with benchmarking of MDMA-assisted psychotherapy

Matters Arising to this article was published on 11 October 2021

The Original Article was published on 10 May 2021

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Mitchell, J. M. et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat. Med. https://doi.org/10.1038/s41591-021-01336-3 (2021).

  2. American Psychological Association. Clinical practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults 1st edn (APA, 2017).

  3. National Institute for Health and Care Excellence. Post-traumatic Stress Disorder. NIC Guideline [NG116] (National Institute for Health and Care Excellence, 2018).

  4. Lee, D. J. et al. Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: Systemic review and meta- analyses to determine first-line treatments. Depress. Anxiety 33, 792–806 (2016).

    CAS  Article  Google Scholar 

  5. Mavranezouli, I. et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol. Med. 50, 542–555 (2020). 130.

    Article  Google Scholar 

  6. Karatzias, T. et al. Psychological interventions for ICD-11 complex PTSD symptoms: systematic review and meta-analysis. Psychol. Med. 49, 1761–1775 (2019). 133.

    Article  Google Scholar 

  7. Ehlers, A. et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am. J. Psychiatry 171, 294–304 (2014).

    Article  Google Scholar 

  8. Springer, K. S., Levy, H. C. & Tolin, D. F. Remission in CBT for adult anxiety disorders: a meta analysis. Clin. Psychol. Rev. 61, 1–8 (2018).

    Article  Google Scholar 

  9. Resick, P. A., Williams, L. F., Suvak, M. K., Monson, C. M. & Gradus, J. L. Long-term outcomes of cognitive-behavioral treatments for posttraumatic stress disorder among female rape survivors. J. Consulting Clin. Psychol. 80, 201–210 (2012).

    Article  Google Scholar 

  10. Schenk, S. & Newcombe, D. Methylenedioxymethamphetamine (MDMA) in psychiatry: pros, cons, and suggestions. J. Clin. Psychopharmacol. 38, 632–638 (2018).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

J. Ø. H. and I. A. C. conceptualized the main arguments, and J. Ø. H. wrote the first draft. J. Ø. H., F. N. and I. A. C. contributed substantially to the revisions of the manuscript.

Corresponding author

Correspondence to Joar Øveraas Halvorsen.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Halvorsen, J.Ø., Naudet, F. & Cristea, I.A. Challenges with benchmarking of MDMA-assisted psychotherapy. Nat Med 27, 1689–1690 (2021). https://doi.org/10.1038/s41591-021-01525-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-021-01525-0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing